134 related articles for article (PubMed ID: 7536032)
1. Detection at diagnosis of tumor cells in bone marrow aspirates of patients with small-cell lung cancer (SCLC) and clinical correlations.
Pasini F; Pelosi G; Mostacci R; Santo A; Masotti A; Spagnolli P; Recaldin E; Cetto GL
Ann Oncol; 1995 Jan; 6(1):86-8. PubMed ID: 7536032
[TBL] [Abstract][Full Text] [Related]
2. Detection of small-cell-lung-cancer cells in bone-marrow aspirates by monoclonal antibodies NCC-LU-243, NCC-LU-246 and MLuC1.
Pasini F; Pelosi G; Ledermann JA; Cetto GL
Int J Cancer Suppl; 1994; 8():53-6. PubMed ID: 8194897
[TBL] [Abstract][Full Text] [Related]
3. [The use of monoclonal antibodies that recognize the neural cell adhesion molecule (NCAM) in the diagnosis of bone marrow localization of small cell lung cancer].
Pasini F; Pelosi G; Santo A; Zaninelli M; Mostacci R; Masotti A; Spagnolli P; Recaldin E; Cetto GL
Minerva Med; 1994 Sep; 85(9):433-8. PubMed ID: 7936364
[TBL] [Abstract][Full Text] [Related]
4. Positive immunostaining with MLuC1 of bone marrow aspirate predicts poor outcome in patients with small-cell lung cancer.
Pasini F; Pelosi G; Verlato G; Guidi G; Pavanel F; Tummarello D; Masotti A; Cetto GL
Ann Oncol; 1998 Feb; 9(2):181-5. PubMed ID: 9553663
[TBL] [Abstract][Full Text] [Related]
5. Detection of the neural cell adhesion molecule (NCAM) in serum of patients with small-cell lung cancer (SCLC) with "limited" or "extensive" disease, and bone-marrow infiltration.
Ledermann JA; Pasini F; Olabiran Y; Pelosi G
Int J Cancer Suppl; 1994; 8():49-52. PubMed ID: 7515029
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of serum neural cell adhesion molecule as a new tumor marker in small cell lung cancer.
Jaques G; Auerbach B; Pritsch M; Wolf M; Madry N; Havemann K
Cancer; 1993 Jul; 72(2):418-25. PubMed ID: 8391379
[TBL] [Abstract][Full Text] [Related]
7. Reactivity of lung tumors with lung-derived and non-lung-derived monoclonal antibodies.
Ioachim HL; Pambuccian S; Giancotti F; Dorsett B
Int J Cancer Suppl; 1994; 8():132-3. PubMed ID: 7515026
[TBL] [Abstract][Full Text] [Related]
8. Effects of different immunolabeling techniques on the detection of small-cell lung cancer cells in bone marrow.
Pelosi G; Pasini F; Pavanel F; Bresaola E; Schiavon I; Iannucci A
J Histochem Cytochem; 1999 Aug; 47(8):1075-88. PubMed ID: 10424892
[TBL] [Abstract][Full Text] [Related]
9. Immunocytologic diagnosis of small-cell lung cancer in imprint smears.
Tome Y; Hirohashi S; Noguchi M; Matsuno Y; Kishi K; Uei Y; Shimosato Y
Acta Cytol; 1991; 35(5):485-90. PubMed ID: 1656682
[TBL] [Abstract][Full Text] [Related]
10. Detection of bone marrow metastases in small cell lung cancer patients. Comparison of immunologic and morphologic methods.
Beiske K; Myklebust AT; Aamdal S; Langholm R; Jakobsen E; Fodstad O
Am J Pathol; 1992 Sep; 141(3):531-8. PubMed ID: 1381558
[TBL] [Abstract][Full Text] [Related]
11. Use of the immunotoxin N901-blocked ricin in patients with small-cell lung cancer.
Epstein C; Lynch T; Shefner J; Wen P; Maxted D; Braman V; Ariniello P; Coral F; Ritz J
Int J Cancer Suppl; 1994; 8():57-9. PubMed ID: 7515030
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies in the detection of bone marrow metastases in small cell lung cancer.
Skov BG; Hirsch FR; Bobrow L
Br J Cancer; 1992 Apr; 65(4):593-6. PubMed ID: 1373295
[TBL] [Abstract][Full Text] [Related]
13. Detection of small cell lung cancer metastases in bone marrow aspirates using monoclonal antibody directed against neuroendocrine differentiation antigen.
Berendsen HH; de Leij L; Postmus PE; Ter Haar JG; Poppema S; The TH
J Clin Pathol; 1988 Mar; 41(3):273-6. PubMed ID: 2834417
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow involvement in small cell lung cancer. Clinical significance and correlation with routine laboratory variables.
Tritz DB; Doll DC; Ringenberg QS; Anderson S; Madsen R; Perry MC; Yarbro JW
Cancer; 1989 Feb; 63(4):763-6. PubMed ID: 2536586
[TBL] [Abstract][Full Text] [Related]
15. Clinical applications of immunocytochemistry in the monitoring of the bone marrow in small cell lung cancer (SCLC).
Hay FG; Ford A; Leonard RC
Int J Cancer Suppl; 1988; 2():8-10. PubMed ID: 2832333
[TBL] [Abstract][Full Text] [Related]
16. NCAM (CD56)-positive malignant lymphoma.
Kern WF; Spier CM; Miller TP; Grogan TM
Leuk Lymphoma; 1993 Dec; 12(1-2):1-10. PubMed ID: 7512851
[TBL] [Abstract][Full Text] [Related]
17. Detection of small cell lung cancer bone marrow involvement by discontinuous gradient sedimentation.
Hunter RF; Broadway P; Sun SL; Niell HB; Mauer AM
Cancer Res; 1987 May; 47(10):2737-40. PubMed ID: 3032414
[TBL] [Abstract][Full Text] [Related]
18. Immunodetection of small cell lung cancer metastases in bone marrow using three monoclonal antibodies.
Canon JL; Humblet Y; Lebacq-Verheyden AM; Manouvriez P; Bazin H; Rodhain J; Prignot J; Symann M
Eur J Cancer Clin Oncol; 1988 Feb; 24(2):147-50. PubMed ID: 2833400
[TBL] [Abstract][Full Text] [Related]
19. Patterns of bone marrow involvement with small cell lung cancer.
Clamon GH; Edwards WR; Hamous JE; Scupham RK
Cancer; 1984 Jul; 54(1):100-2. PubMed ID: 6326994
[TBL] [Abstract][Full Text] [Related]
20. Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres.
Jørgensen LG; Osterlind K; Genollá J; Gomm SA; Hernández JR; Johnson PW; Løber J; Splinter TA; Szturmowicz M
Br J Cancer; 1996 Aug; 74(3):463-7. PubMed ID: 8695366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
